A new study provides important insights into the pharmacokinetics and safety of intravenous remdesivir in treating the SARS-CoV-2 coronavirus in pregnant women.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
College of American Pathologists (CAP) Accreditation Signifies the Highest Standards in Laboratory Practice GOLDEN, Colo., Nov. 28, 2022 /PRNewswire/ — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision oncology company with a novel […]
Doctors and researchers at the University of Colorado Anschutz Medical Campus published a discussion paper today highlighting key initiatives to help strengthen, train and prepare doctors and health care workers for the impact of climate […]
Some people call it the “October Slide.” As the nights grow colder and the days grow darker, everything from drops in barometric pressure to daylight saving time can make people feel, well, under the weather. […]
Copyright © 2026 Biotech Networks
